Kunisada et al. demonstrated that metformin reduced the number of tumor-infiltrating Tregs by inhibiting differentiation of naïve CD4+ T-cells into Tregs through forkhead box P3 (Foxp3) protein [118]. The gene discussed is FOXP3; the disease is neoplasm.